Management of locally advanced breast cancer

ONCOLOGY

Volumn 11, Issue 9 SUPPL., 1997, Pages 9-17

  Perez, Edith A ^a   Foo, May L ^a   Fulmer, Jack T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADVANCED CANCER; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DRUG MEGADOSE; HUMAN; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; TUMOR LOCALIZATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PREOPERATIVE CARE; PROGNOSIS;

EID: 0030848659     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Bloom HJ, Richardson WW, Harris EJ: The natural history of untreated breast cancer. Br Med J 2:213-221, 1962.
2. Beahrs OH, Henson DE, Hutter RV, et al: Handbook for Staging of Cancer, 4th ed. pp 161-168. Philadelphia, IB Lippincott, 1993
3. Heys SD, Eremin JM, Sarkar TK, et al: Role of multimodality therapy in the management of locally advanced carcinoma of the breast. J Am Coll Surg 179:493-504, 1994.
4. Yeatman TJ: The natural history of locally advanced primary breast carcinoma and metastatic disease. Surg Oncol Clin North Am 4:569-589, 1995.
5. Shen ZZ, Zhang YW, Pan TX, et al: Multidisciplinary approach to the treatment of unresectable breast cancer. World J Surg 19:843-846, 1995.
6. Winchester DP, Cox JD: Standards for breast-conservation treatment. CA Cancer J Clin 42:134-162, 1992.
7. Gould EW, Robinson PG: The pathologist' s examination of the "lumpectomy" - The pathologists' view of surgical margins. Semin Surg Oncol 8:129-135, 1992.
8. Vicini FA, Eberlein TJ, Connolly JL, et al: The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 214:200-204, 204-205 (discussion), 1991.
9. Gwin IL, Eisenberg BL, Hoffman IP, et al: Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after reexcision lumpectomy. Ann Surg 218:729-734, 1993.
10. Kearney TJ, Morrow M: Effect of reexcision on the success of breast-conserving surgery. Ann Surg Oncol 2:303-307, 1995.
11. Schnitt SJ, Abner A, Gelman R, et al: The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74:1746-1751, 1994.
12. Bedwinek J: Breast conserving surgery and irradiation: The importance of demarcating the excision cavity with surgical clips. Int J Radiat Oncol Biol Phys 26:675-679, 1993.
13. Goodman AA, Mendez AL. Definitive surgery for breast cancer performed on an outpatient basis. Arch Surg 128:1149-1152, 1993.
14. Weltz CR, Greengrass RA, Lyerly HK: Ambulatory surgical management of breast carcinoma. Ann Surg 222:19-26, 1995.
15. Kent AL, Eaton M, Marshall N, et al: Locally advanced breast cancer: Is surgery warranted following chemotherapy? Aust N Z J Surg 65:229-232, 1995.
16. Touboul E, Lefranc JP, Blondon J, et al: Multidisciplinary treatment approach to locally advanced non-inflammatory breast cancer using chemotherapy and radiotherapy with or without surgery. Radiother Oncol 25:167-175, 1992.
17. Schwartz GF, Birchansky CA, Komarnicky LT, et al: Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73:362-369, 1994.
18. Veronesi U, Bonadonna G, Zurrida S, et al: Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 222:612-618, 1995
19. Bonadonna G, Veronesi U, Brambilla C, et al: Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82:1539-1545, 1990.
20. Touboul E, Buffat L, Lefranc JP, et al: Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 34:1019-1028, 1996.
21. Arriagada R, Mouriesse H, Sarrazin D, et al: Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control The experience of the Gustave-Roussy Institute and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 11:1751-1757, 1985.
22. Chu AM, Cope O, Doucette J, et al: Non-metastatic locally advanced cancer of the breast treated with radiation. Int J Radiat Oncol Biol Phys 10:2299-2304, 1984.
23. Puthawala AA, Syed AM, Sheikh KM, et al: Combined external and interstitial irradiation in the treatment of stage III breast cancer. Radiology 153:813-816, 1984.
24. Balawajder I, Antich PP, Boland J: An analysis of the role of radiotherapy alone and in combination with chemotherapy and surgery in the management of advanced breast carcinoma. Cancer 51:574-580, 1983.
25. Ahem V, Barraclough B, Bosch C, et al: Locally advanced breast cancer: Defining an optimum treatment regimen. Int J Radiat Oncol Biol Phys 28:867-875, 1994.
26. DeLena M, Zucali R, Viganotti G, et al. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1:53-59, 1978.
27. Bedwinek J, Rao DV, Perez C, et al: Stage III and localized stage IV breast cancer: Irradiation alone vs irradiation plus surgery. Int J Radiat Oncol Biol Phys 8:31-36, 1982.
28. Swain SM, Sorace RA, Bagley CS, et al: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer Cancer Res 47:3889-3894, 1987.
29. Jacquillat C, Baillet F, Weil M, et al: Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB). Cancer 61: 1977-1982, 1988.
30. Perloff M, Lesnick GJ, Korzun A, et al: Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: A Cancer and Leukemia Group B study. J Clin Oncol 6:261-269, 1988.
31. Pierce LJ, Lippman M, Ben-Baruch N, et al: The effect of systemic therapy on local-regional control in locally advanced breast cancer. Int J Radiat Oncol Biol Phys 23:949-960, 1992.
32. Inskip PD, Boice JD Jr: Radiotherapy-induced lung cancer among women who smoke. Cancer 73,1541-1543, 1994.
33. Neugut AI, Robinson E, Lee WC: Lung cancer after radiation therapy for breast cancer Cancer 71:3054-3057, 1993.
34. Neugut AI, Murray T, Santos J, et al: Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 73:1615-1620, 1994.
35. Harvey EB, Brinton LA: Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:99-112, 1985.
36. Cafiero F, Gipponi M, Peressini A, et al: Radiation-associated angiosarcoma: Diagnostic and therapeutic implications - Two case reports and a review of the literature. Cancer 77:2496-2502, 1996.
37. Shannon VR, Nesbitt JC, Libshitz HI: Malignant pleural mesothelioma after radiation therapy for breast cancer: A report of two additional patients. Cancer 76:437-441, 1995.
38. Hortobagyi G, Singletary S, McNeese M: Treatment of locally advanced and inflammatory breast cancer, in Harris J, Lippman M, Morrow M, (eds): Diseases of the Breast, pp 585-600. Philadelphia, Lippincott-Raven, 1996.
39. Borger JH, van Tienhoven G, Passchier DH, et al: Primary radiotherapy of breast cancer: Treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy. Radiother Oncol 25:1-11, 1992.
40. Klassen U, Wilke H, Seeber S: Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Semin Oncol 23(suppl 11): 1-5, 1996.
41. Schaake-Koning C, van der Linden EH, Hart G, et al: Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: A randomized clinical study. Int J Radiat Oncol Biol Phys 11:1759-1763, 1985.
42. Rubens RD, Bartelink H, Engelsman E, et al: Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapy: An EORTC Breast Cancer Cooperative Group Trial (10792). Eur J Cancer Clin Oncol 25:667-678, 1989.
43. Calais G, Berger C, Descamps P, et al: Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74:1283-1288, 1994.
44. Scholl SM, Fourquet A, Asselain B, et al: Neoadjuvant vs adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery Preliminary results of a randomised trial: S6. Eur J Cancer 30A,645-652, 1994.
45. Booser D, Frye D, Singletary S, et al: Response to induction chemotherapy for breast cancer: A prospective multimodality treatment program (abstract). Proc Am Soc Clin Oncol 11:82, 1992.
46. Hortobagyi GN, Ames FC, Buzdar AU, et al: Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62:2507-2516, 1988.
47. Trudeau ME. Docetaxel (Taxotere): An overview of first-line monotherapy. Semin Oncol 22-17-21, 1995.
48. Piccart M, Docetaxel: A new defense in the management of breast cancer. Anticancer Drugs 6:7-11, 1995.
49. Seidman AD, Hudis CA, Norton L: Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: From advanced disease to adjuvant therapy. Semin Oncol 22:3-8, 1995
50. Holmes FA: Update: The M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma. Semin Oncol 22:9-15, 1995.
51. Gianni L, Munzone E, Capri G, et al: Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 13:2688-2699, 1995.
52. Gianni L, Capri G, Tarenzi E, et al: Efficacy and cardiac effects of 3-H paclitaxel (P) plus bolus doxorubicin (DOX) in women with untreated metastatic breast carcinoma (abstract). Proc Am Soc Clin Oncol 15:116, 1996.
53. Gianni L, Demicheli R, Moliterni A, et al: Pilot study of primary chemotherapy with doxorubicin-paclitaxel (AT) in women with T2-T3 locally advanced breast carcinoma (abstract). Proc Am Soc Clin Oncol 15:116, 1996.
54. deMagalhaes-Silverman M, Rybka WB, Lembersky B, et al: High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer. Am J Clin Oncol 19:169-173, 1996.
55. Mulder NH, Mulder PO, Sleijfer DT, et al: Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer. Eur J Cancer 29A:668-671, 1993.
56. Rutgers EJ, Richel DJ, Baars JW, et al: Preliminary analysis of a randomized phase II study of high-dose chemotherapy in high-risk breast cancer (abstract). Eur J Cancer 32A:34, 1996.
57. Colozza M, Gori S, Mosconi AM, et al: Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer: Long-term results. Am J Clin Oncol 19:10-17, 1996.
58. Forrest AP, Stewart HJ, Roberts MM, et al: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196:371-378, 1982.
59. Schwartzberg L, Birch R, Weaver C, et al: Neoadjuvant chemotherapy with or without paclitaxel and high dose chemotherapy with peripheral blood progenitor cell (PBSC) support for locally advanced breast cancer (LABC) (abstract). Proc Am Soc Clin Oncol 15:124, 1996.
60. Helvie MA, Joynt LK, Cody RL, et al: Locally advanced breast carcinoma: Accuracy of mammography vs clinical examination in the prediction of residual disease after chemotherapy. Radiology 198:327-332, 1996.
61. Pierce L, Adler D, Helvie M, et al: The use of mammography in breast preservation in locally advanced breast cancer. Int J Radiat Oncol Biol Phys 34:571-577, 1996.
62. Abraham DC, Jones RC, Jones SE, et al: Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78:91-100, 1996.
63. Percivale P, Bertoglio S, Meszaros P, et al: Radioimmunoguided surgery after primary treatment of locally advanced breast cancer. J Clin Oncol 14:1599-1603, 1996.
64. Gardin G, Alama A, Rosso R, et al: Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer. Breast Cancer Res Treat 32-311-318, 1994.
65. Masood S. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers. Surg Oncol Clin North Am 4:601-632, 1995.
66. Archer SG, Eliopoulos A, Spandidos D, et al: Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. Br J Cancer 72:1259-1266, 1995.
67. Decker DA, Morris LW, Levine AJ, et al: Immunohistochemical analysis of P-glycoprotein expression in breast cancer: Clinical correlations. Ann Clin Lab Sci 25:52-59, 1995.